Sorlandet Hospital
Kristiansand, Vest Agder, 4604, Norway
NCT Number: NCT03453788
This pilot study is evaluating a new smartphone application named the LETSGO app. The LETSGO app is designed to promote empowerment in patients after treatment for gynecological cancer.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Kristiansand, Vest Agder, 4604, Norway
Gynecological cancer treatment is increasingly successful, resulting in a rising number of cancer survivors. Many gynecological cancer survivors may experience late side effects from their cancer treatment. In addition, evidence is accumulating that an active lifestyle may increase empowerment and may positively influence well-being after cancer treatment. Through the LETSGO smartphone app, women treated for gynecological cancer will get access to individualized posttreatment information on side effects as well as tailored physical activity advices in order to assume more responsibility for achieving the best outcomes from her care. The participants will also regularly answer patient reported outcomes regarding possible recurrence though the app. As a first step the smart-phone application will be pilot-tested.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
LETSGO pilot test Group will test LETSGO app and partially nurseled follow-up
Time frame: 8 months
Evaluate satisfaction with app through patient interviews
Time frame: 6 months
Evaluate the patient recruitment rate
Time frame: 8 months
Evaluate acceptability of goalsetting through changes in Activity level
Sorlandet Hospital HF
Other Gov
Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology: Pilot Study
Acronym: LETSGO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04122235
Adnexal Diseases, Alzheimer Disease
Gjøvik, Oppland, Norway
View Trial DetailsNCT05666947
Behavior, Exercise
View Trial DetailsNCT05131815
Astrocytoma, Behavior
Los Angeles, California, United States
View Trial DetailsNCT04354454
Behavior, Gynecologic Cancer
Brewer, Maine, United States
View Trial Details